LEXICON PHARMACEUTICALS INC's ticker is and the CUSIP is 528872AB0. A total of 12 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $21,586,000,000 | -20.4% | 12,000,000 | 0.0% | 0.42% | +3.5% |
| Q3 2016 | $27,118,000,000 | +20.4% | 12,000,000 | 0.0% | 0.40% | -17.1% |
| Q2 2016 | $22,523,000,000 | +64.2% | 12,000,000 | +41.2% | 0.49% | +92.9% |
| Q1 2016 | $13,714,000,000 | -8.3% | 8,500,000 | 0.0% | 0.25% | 0.0% |
| Q4 2015 | $14,952,000,000 | – | 8,500,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 6,500,000 | $10,540,000 | 3.34% |
| LINDEN ADVISORS LP | 20,125,000 | $32,329,000 | 1.79% |
| ANGELO GORDON & CO., L.P. | 8,000,000 | $12,920,000 | 0.93% |
| Verition Fund Management LLC | 2,000,000 | $3,240,000 | 0.52% |
| WOLVERINE ASSET MANAGEMENT LLC | 8,000,000 | $12,859,000 | 0.37% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 8,500,000 | $13,714,000,000 | 0.25% |
| LAZARD ASSET MANAGEMENT LLC | 8,250,000 | $13,365,000 | 0.03% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 12,000,000 | $19,225,000 | 0.02% |
| Citadel Advisors | 9,100,000 | $14,660,000 | 0.02% |
| ClearBridge Investments | 3,000,000 | $4,960,000 | 0.01% |